These two proteins, p16INK4A and p14ARF, are important regulators of the retinoblastoma (Rb) and p53 pathways, respectively, and their gene promoters have been found to be hypermethylated and, consequently, silenced in both primary and metastatic melanoma [65,67]. The gene discussed is CDKN2A; the disease is metastatic melanoma.